Be Familiar With the Latest Oral Multiple Sclerosis Meds

November 2020

You'll hear about a flurry of new ORAL meds to treat multiple sclerosis (MS)...such as Mayzent, Vumerity, and Zeposia.

Expect patients with relapsing-remitting MS to usually start treatment right away...to reduce flares and slow progression.

We're used to seeing the injectables (Avonex, Copaxone, etc) first-line. Or patients with more severe disease may jump right to a monoclonal antibody IV infusion (Lemtrada, Tysabri, etc).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote